RECURSION PHARMACEUTICALS, INC. Quarterly Depreciation in USD from Q1 2020 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Recursion Pharmaceuticals, Inc. quarterly/annual Depreciation history and growth rate from Q1 2020 to Q4 2024.
  • Recursion Pharmaceuticals, Inc. Depreciation for the quarter ending December 31, 2024 was $6.2M, a 51.2% increase year-over-year.
  • Recursion Pharmaceuticals, Inc. Depreciation for the twelve months ending December 31, 2024 was $18.3M, a 15.1% increase year-over-year.
  • Recursion Pharmaceuticals, Inc. annual Depreciation for 2024 was $18.3M, a 15.1% increase from 2023.
  • Recursion Pharmaceuticals, Inc. annual Depreciation for 2023 was $15.9M, a 39.5% increase from 2022.
  • Recursion Pharmaceuticals, Inc. annual Depreciation for 2022 was $11.4M, a 29.5% increase from 2021.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 $18.3M $6.2M +$2.1M +51.2% Oct 1, 2024 Dec 31, 2024 10-K 2025-02-28
Q3 2024 $16.2M $4M -$200K -4.76% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-06
Q2 2024 $16.4M $4.1M +$100K +2.5% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $16.3M $4M +$400K +11.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $15.9M $4.1M +$1M +32.3% Oct 1, 2023 Dec 31, 2023 10-K 2025-02-28
Q3 2023 $14.9M $4.2M +$1.3M +44.8% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-06
Q2 2023 $13.6M $4M +$1.3M +48.1% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $12.3M $3.6M +$900K +33.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $11.4M $3.1M +$600K +24% Oct 1, 2022 Dec 31, 2022 10-K 2025-02-28
Q3 2022 $10.8M $2.9M +$400K +16% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $10.4M $2.7M +$300K +12.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $10.1M $2.7M +$1.3M +92.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 $8.8M $2.5M +$1.4M +127% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-29
Q3 2021 $7.4M $2.5M +$1.4M +127% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $6M $2.4M +$1.4M +140% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $4.6M $1.4M +$400K +40% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $4.2M $1.1M Oct 1, 2020 Dec 31, 2020 10-K 2023-02-27
Q3 2020 $1.1M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $1M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-13
Q1 2020 $1M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.